Table 1.
Ad/vIL-10 Treatment group | Ratio
|
|
---|---|---|
Lung/serum | Liver/serum | |
i.t. Ad/hIL-10 | 36.8 ± 15.0 | ND |
Ad/vIL-10 | 481.9 ± 204.4 | ND |
i.v. Ad/hIL-10 | 0.03 ± 0.01 | 0.12 ± 0.05 |
Ad/vIL-10 | 0.15 ± 0.01 | 1.82 ± 0.25 |
ND, not determined.
Ad/vIL-10 Treatment group | Ratio
|
|
---|---|---|
Lung/serum | Liver/serum | |
i.t. Ad/hIL-10 | 36.8 ± 15.0 | ND |
Ad/vIL-10 | 481.9 ± 204.4 | ND |
i.v. Ad/hIL-10 | 0.03 ± 0.01 | 0.12 ± 0.05 |
Ad/vIL-10 | 0.15 ± 0.01 | 1.82 ± 0.25 |
ND, not determined.